Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma
Stopped The Cediranib producer laboratory decided to stop the development of this product.
Conditions
- Uveal Melanoma
- Metastatic Cancer
Interventions
- DRUG: Cediranib Maleate
- DRUG: Durvalumab
Sponsor
Grupo Español Multidisciplinar de Melanoma
Collaborators